Evidence map›Paper›PMID 37029420›Full record

ArticleClinical epigenetics2023

Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m

Yili Ping, Jingjuan Huang, Jichao Zhu, Zujun Sun, Anquan Shang, Chen Chen, Wenfang Liu, Dong Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical epigenetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yili Ping *Department of Laboratory Medicine, Shanghai Tongji Hospital, Tongji University, School of Medicine, Shanghai, 200065, China.
Jingjuan Huang *Department of Laboratory Medicine, Shanghai Tongji Hospital, Tongji University, School of Medicine, Shanghai, 200065, China.
Jichao ZhuDepartment of Laboratory Medicine, Huzhou Central Hospital, Huzhou, 313099, China.
Zujun SunDepartment of Laboratory Medicine, Shanghai Tongji Hospital, Tongji University, School of Medicine, Shanghai, 200065, China.
Anquan ShangDepartment of Laboratory Medicine, Shanghai Tongji Hospital, Tongji University, School of Medicine, Shanghai, 200065, China.
Chen ChenDepartment of Laboratory Medicine, Shanghai Tongji Hospital, Tongji University, School of Medicine, Shanghai, 200065, China.
Wenfang LiuDepartment of General Surgery, Shanghai Tongji Hospital, Tongji University, School of Medicine, Shanghai, 200065, China. lwf112@163.com.
Dong LiDepartment of Laboratory Medicine, Shanghai Tongji Hospital, Tongji University, School of Medicine, Shanghai, 200065, China. lidong@tongji.edu.cn.
Tongji Hospital · CNTongji University · CNHuzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung adenocarcinoma (LUAD) has a high incidence and recurrence rate. N6-methyladenosine (m

resultsThe m

conclusionsThese data have demonstrated that differential RNA m

Indexed as

AdenocarcinomaLung NeoplasmsRNA, Long NoncodingBiomarkers, TumorDNA MethylationGene Expression ProfilingHumansLungPrognosisBiomarkers, TumorRNA, Long NoncodingBioinformatics analysisLncRNALung adenocarcinomaN6-methyladenosinePrognostic values

Identifiers

PMID37029420
PMCPMC10082542
OpenAlexW4362706464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.